Juvenile chronic myeloid leukemia: Therapeutic insights Journal Article


Authors: Laver, J.; Kushner, B. H.; Steinherz, P. G.
Article Title: Juvenile chronic myeloid leukemia: Therapeutic insights
Abstract: Twelve children with juvenile chronic myeloid leukemia (JCML) received chemotherapy or bone marrow transplants. The median survival of the patients treated with myelosuppressive agents was 19 months. These results demonstrate that intensive chemotherapeutic and supportive measures can prolong survival in JCML but do not affect ultimate outcome. Purported differentiation inducers - low dose ara-C and 13-cis-retinoic acid - were not effective in two patients. Two patients were prepared for bone marrow transplantation with standard antileukemic cytoreduction regimens; one died very early post-transplant, and the other had early reemergence of his disease. The third transplant patient underwent transplantation after his disease had entered an accelerated phase. He received a different immunosuppressive pretransplant regimen, but the leukemia recurred. The latter two patients initially engrafted with mismatched T cell-depleted marrow grafts, but had recurrence of the disease. Our data suggest that marrow transplantation is possible for JCML patients without HLA-identical donors, but for successful marrow transplantation different measures are necessary to eradicate the abnormal stem cell compartment.
Keywords: child; unclassified drug; busulfan; hydroxyurea; prednisone; cancer combination chemotherapy; cyclophosphamide; chronic myeloid leukemia; infant; leukemia, myeloid; idarubicin; amsacrine; isotretinoin; bone marrow transplantation; azacitidine; diaziquone; 10 deazaaminopterin; ancitabine; edatrexate; human; male; 11 deoxydoxorubicin
Journal Title: Leukemia
Volume: 1
Issue: 10
ISSN: 0887-6924
Publisher: Nature Publishing Group  
Date Published: 1987-10-01
Start Page: 730
End Page: 733
Language: English
PUBMED: 3312835
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 5 February 2021 -- Source: Scopus
Citation Impact
MSK Authors
  1. Brian Kushner
    311 Kushner
  2. Peter G Steinherz
    221 Steinherz
  3. Joseph Laver
    29 Laver